.Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01A_AntiinflammatoryAndAntirheumaticProductsNonStero.M01AC06_Meloxicam.Meloxicam .Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01A_AntiinflammatoryAndAntirheumaticProductsNonStero.M01AC06_Meloxicam.Meloxicam| name: | Meloxicam |
| ATC code: | M01AC06 | route: | oral |
| n-compartments | 2 |
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class, used to relieve pain and inflammation in rheumatic diseases and osteoarthritis. It acts primarily by inhibiting cyclooxygenase-2 (COX-2). Meloxicam is widely approved for use in the treatment of osteoarthritis, rheumatoid arthritis, and related inflammatory conditions.
Pharmacokinetic parameters reported for healthy adult volunteers after single oral dose administration.
Zordan, MA, et al., & Sánchez, CR (2016). Population pharmacokinetics of a single dose of meloxicam after oral and intramuscular administration to captive lesser flamingos (Phoeniconaias minor). American journal of veterinary research 77(12) 1311–1317. DOI:10.2460/ajvr.77.12.1311 PUBMED:https://pubmed.ncbi.nlm.nih.gov/27901389
Dhondt, L, et al., & Antonissen, G (2017). Comparative population pharmacokinetics and absolute oral bioavailability of COX-2 selective inhibitors celecoxib, mavacoxib and meloxicam in cockatiels (Nymphicus hollandicus). Scientific reports 7(1) 12043–None. DOI:10.1038/s41598-017-12159-z PUBMED:https://pubmed.ncbi.nlm.nih.gov/28947805
Goodnight, AL, & Cox, S (2018). PHARMACOKINETICS OF MELOXICAM FOLLOWING A SINGLE ORAL DOSE IN MALAYAN FLYING FOXES ( PTEROPUS VAMPYRUS). Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians 49(2) 307–314. DOI:10.1638/2017-0067.1 PUBMED:https://pubmed.ncbi.nlm.nih.gov/29900779